Literature DB >> 11529832

Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism.

F F Chou1, J B Chen, C H Lee, S H Chen, S M Sheen-Chen.   

Abstract

HYPOTHESIS: The recovery of osteoporosis or bone mineral density (BMD) after parathyroidectomy and autotransplantation can be improved in patients with symptomatic secondary hyperparathyroidism.
DESIGN: Case series.
SETTING: Tertiary referral center. PATIENTS: Forty-five patients with symptomatic secondary hyperparathyroidism who underwent total parathyroidectomy and autotransplantation were included. They were divided into an osteoporotic group (n = 20) and a nonosteoporotic group (n = 25) according to preoperative T scores less than -2.5 at either the lumbar spine (L1-L4) or the femoral neck (FN).
INTERVENTIONS: Serum levels of calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone were checked before surgery and 1 day, 1 week, and 3 months after surgery. The BMDs of the FN and L1-L4 were measured using dual-energy x-ray absorptiometry before surgery and 6 months after surgery.
RESULTS: Patients with osteoporosis were older (mean +/- SD, 50.2 +/- 14.0 years) than those without osteoporosis (42.7 +/- 9.1 years) (P =.04). Except for bone fractures found in 2 women in the osteoporotic group, there were no significant differences between the 2 groups in sex, clinical manifestations, duration of dialysis, weight of removed parathyroid tissue, and types of dialysis. Also, serum levels of calcium, phosphorus, alkaline phosphatase, and intact parathyroid hormone were similar in both groups. Both 1 day and 1 week after total parathyroidectomy and autotransplantation, serum levels of calcium and intact parathyroid hormone decreased rapidly and then gradually increased 3 months later; however, serum levels of alkaline phosphatase increased rapidly and then gradually decreased 3 months later. Six months after parathyroidectomy, BMD, T score, and Z score at L1-L4 and the FN increased significantly (P<.001). The increment was much better in the osteoporotic group than in the nonosteoporotic group (P<.001). Also, osteopenia or osteoporosis improved significantly after parathyroidectomy at both L1-L4 and the FN (P<.001 for both).
CONCLUSION: Parathyroidectomy and autotransplantation can improve BMD of symptomatic secondary hyperparathyroidism at L1-L4 and the FN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529832     DOI: 10.1001/archsurg.136.9.1064

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  12 in total

1.  Is three-gland-or-less parathyroidectomy a clinical failure for secondary hyperparathyroidism?

Authors:  Tolga Özmen; Manuk Manukyan; Semiha Şen; Arzu Kahveci; Cumhur Yeğen; Bahadır Mahmut Güllüoğlu
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

Review 2.  Old and New Drugs for the Management of Bone Disorders in CKD.

Authors:  Hirotaka Komaba; Markus Ketteler; John Cunningham; Masafumi Fukagawa
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

Review 3.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

4.  Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Yuki Tsuruta; Kazuhiro Okano; Kan Kikuchi; Yukio Tsuruta; Takashi Akiba; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-07-26       Impact factor: 2.801

Review 5.  Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.

Authors:  S N Salam; A Khwaja; M E Wilkie
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

Review 6.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

7.  Bipolar Hemiarthroplasty and Parathyroidectomy at the Same Setting for Fragility Fractures Secondary to Renal Bone Disease.

Authors:  Amila Silva; Adriel You Wei Tay; Chung Fai Jeremy Ng; Tet Sen Howe
Journal:  Indian J Orthop       Date:  2020-06-03       Impact factor: 1.251

Review 8.  Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis.

Authors:  Mugurel Apetrii; David Goldsmith; Ionut Nistor; Dimitrie Siriopol; Luminita Voroneanu; Dragos Scripcariu; Marc Vervloet; Adrian Covic
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

9.  Treatment of hypocalcemia in hungry bone syndrome: A case report.

Authors:  Farahnaz Anwar; Joseph Abraham; Ahmad Nakshabandi; Eugene Lee
Journal:  Int J Surg Case Rep       Date:  2018-08-13

Review 10.  Parathyroid Hormone: A Uremic Toxin.

Authors:  Eduardo J Duque; Rosilene M Elias; Rosa M A Moysés
Journal:  Toxins (Basel)       Date:  2020-03-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.